marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q3
added 11-09-2023
Harpoon Therapeutics Financial Ratios 2011-2024 | HARP
Annual Financial Ratios Harpoon Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.3 | -1.5 | -9.7 | -5.3 | - | - | - | - | - | - | - | - |
P/S |
0.7 | 7.2 | 27.7 | 50.7 | - | - | - | - | - | - | - | - |
EPS |
-2.0 | -3.6 | -2.0 | -2.6 | -25.6 | -18.8 | -21.6 | - | - | - | - | - |
EV (Enterprise Value) |
38.3 M | 223 M | 579 M | 286 M | 66.6 M | 29.4 M | 17.8 M | - | - | - | - | - |
EBITDA per Share |
-1.99 | -3.55 | -1.97 | -2.64 | - | - | - | - | - | - | - | - |
EV/EBITDA |
-1.9 | -9.4 | -3.6 | - | - | - | - | - | - | - | - | |
PEG |
- | 0.44 | -0.04 | - | - | - | - | - | - | - | - | |
P/B |
4.0 | 2.9 | 9.0 | 3.1 | - | - | - | - | - | - | - | - |
P/CF |
-0.2 | -1.4 | -56.0 | -45.7 | - | - | - | - | - | - | - | - |
ROE % |
-1254.51 | -201.00 | -92.70 | -58.98 | - | - | - | - | - | - | - | - |
ROA % |
-91.86 | -75.08 | -29.09 | -31.47 | - | - | - | - | - | - | - | - |
ROCE % |
-1265.51 | -201.05 | -95.34 | -37.77 | - | - | - | - | - | - | - | - |
Current Ratio |
1.1 | 1.6 | 1.5 | 6.7 | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Harpoon Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.46 | 0.03 | -0.31 | - | -3.52 | -0.53 | -0.62 | - | -0.51 | -0.52 | -1.95 | -0.45 | -0.53 | -0.51 | -0.51 | -0.58 | -0.65 | -0.49 | -1.01 | -8.15 | -6.23 | -5.89 | -5.04 | -5.27 | -5.35 | -4.24 | -3.86 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-3.02 | 0.08 | -0.27 | - | -3.44 | -0.51 | -0.6 | - | -0.46 | -0.48 | -1.94 | -0.46 | -0.48 | -0.48 | -0.51 | -0.6 | -0.66 | -0.5 | -1.03 | -8.27 | -5.9 | -5.67 | -4.97 | -5.32 | -5.36 | -4.12 | -3.56 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-1950.27 | -1979.42 | -2079.93 | -183.06 | -204.73 | -157.58 | -110.89 | -100.40 | -121.49 | -124.54 | -129.67 | -92.70 | -86.75 | -78.92 | -67.88 | -58.98 | -25.64 | 3.88 | 27.63 | 51.17 | 32.98 | 20.34 | 9.13 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-30.08 | -40.23 | -57.84 | -45.21 | -54.76 | -50.37 | -42.99 | -41.72 | -48.33 | -46.54 | -45.39 | -29.09 | -30.55 | -31.80 | -31.09 | -31.47 | -32.87 | -30.46 | -29.61 | -26.68 | -17.19 | -10.60 | -4.76 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-2036.75 | -1839.73 | -1988.23 | -184.74 | -206.40 | -157.76 | -110.85 | -100.44 | -121.79 | -125.37 | -131.28 | -95.34 | -89.70 | -82.08 | -71.16 | -61.78 | -27.61 | 2.82 | 27.56 | 51.84 | 51.93 | 39.12 | 27.80 | 18.54 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.1 | 1.1 | 1.0 | 1.1 | 1.2 | 1.3 | 1.4 | 1.6 | 1.8 | 1.9 | 1.6 | 1.5 | 1.5 | 1.5 | 1.5 | 2.1 | 2.1 | 2.1 | 2.1 | 3.9 | 3.9 | 3.9 | 3.9 | 1.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency